Related Experiment Videos
Anesthesia for the micropremie
J P Spaeth1, I B O'Hara, C D Kurth
1Department of Anesthesiology and Critical Care, The Children's Hospital of Philadelphia, and the University of Pennsylvania School of Medicine, 19104, USA.
Abstract:
Providing anesthesia for the micropremie involves many considerations beyond what is needed for the full-term neonate. Immaturity of the airway, lungs, cardiovascular system, liver, kidneys, and central nervous system makes the micropremie susceptible to anesthestic complications. Immature respiratory mechanisms and respiratory control increase the risk of apnea, hypoxemia, and hypercapnia intraoperatively as well as postoperatively. Anesthetic drugs depress myocardial contractility and impair baroreflexes in the micropremie to increase the risk of hypotension during anesthesia. Drug metabolism in the micropremie is slow because of the immature liver and kidneys. The micropremie brain requires less drug to achieve the anesthetized state. As a result, administration of the dose and timing of anesthetic drugs differs in the micropremie compared with the full-term neonate. This article describes anesthetic considerations for a few surgical prodedures common in the micropremie.
Insights
Anesthesia for micropremies requires special care due to immature organ systems, increasing complication risks. Dosing and timing of anesthetic drugs must differ from full-term neonates for safety.
Area of Science:
- Anesthesiology
- Neonatal Medicine
- Pediatric Surgery
Background:
- Micropremature infants possess immature organ systems, including the airway, lungs, cardiovascular system, liver, kidneys, and central nervous system.
- These physiological immaturities predispose micropremies to a higher risk of anesthetic complications compared to full-term neonates.
- Immature respiratory control and mechanisms heighten the likelihood of intraoperative and postoperative apnea, hypoxemia, and hypercapnia.
Purpose of the Study:
- To outline critical anesthetic considerations specific to micropremature infants undergoing common surgical procedures.
- To highlight the unique physiological challenges posed by micropremies during anesthesia.
- To emphasize the differences in anesthetic drug administration and timing required for micropremies versus full-term neonates.
Main Methods:
- Review of anesthetic management strategies for micropremature infants.
- Analysis of physiological differences between micropremies and full-term neonates relevant to anesthesia.
- Description of anesthetic protocols for common surgical procedures in micropremies.
Main Results:
- Micropremies exhibit increased susceptibility to anesthetic complications due to immature organ systems.
- Anesthetic drugs can depress myocardial contractility and impair baroreflexes, elevating the risk of hypotension.
- Slow drug metabolism and reduced drug requirements for the central nervous system necessitate adjusted dosing and timing.
Conclusions:
- Anesthetic management for micropremies demands a tailored approach, differing significantly from that of full-term neonates.
- Careful consideration of the micropremie's immature physiology is crucial for mitigating anesthetic risks.
- Specific anesthetic protocols are essential for ensuring the safety and efficacy of procedures in this vulnerable population.